Exxon Mobil Corporation (XOM): The Mega-Cap Company’s Quarter Was Really Very Solid

Page 1 of 2

Exxon Mobil Corporation (NYSE:XOM)Exxon Mobil Corporation (NYSE:XOM), the 500-pound gorilla of the integrated oil set reported its results for the first quarter of 2013 on Thursday, and the market was unimpressed. Nevertheless, the company’s performance was essentially in line with what those who had observed CEO Rex Tillerson’s comments at a March analyst presentation might have foreseen.

Just the facts
For the quarter, Exxon Mobil Corporation (NYSE:XOM) reported net income of $9.5 billion, or $2.12 per share. That was higher than the $9.45 billion and $2.00 per share for the first quarter of 2012. It also comfortably topped the $2.05-per-share consensus that the analysts who follow Exxon had anticipated. Revenues for the quarter were $108.8 billion, a reduction from last year’s $124.1 billion.

The revenue slide resulted from expected production declines, along with reductions in commodities realizations. Specifically, oil and liquids production was down 3.5% year over year, but slipped only 1.2% when allowing for the effects of entitlement volumes, OPEC quota effects, and divestments. At the same time, crude prices were down $8.66 a barrel from the comparable year-ago quarter.

On the natural gas side, the largest producer of that particular hydrocarbon in the U.S. participated in the price-driven production reduction that was initiated by Chesapeake Energy Corporation (NYSE:CHK), the nation’s No. 2 producer. As a result, gas production was 8.7% lower domestically, which led to a 5.9% global pullback in natural gas output.

Downstream, earnings were off slightly more than 2.5%. However, refinery margins were actually stronger than in the year-ago quarter — which led to a more than $1 billion, or 72%, ,hike in U.S. refining profits — but that strengthening was offset globally by increased expenses, reduced gains on asset sales, and foreign exchange effects. In a related area, earnings from chemicals grew by 62% to $639 million.

What lies ahead?
This look at the past quarter at Exxon Mobil Corporation (NYSE:XOM) is obviously instructional, but a focus on the future reveals far more about the company’s attractiveness as a Foolish energy investment. Indeed, I’m unable to muster any real surprise about the performance. (Indeed, as David Rosenthal, Exxon’s investor relations vice president, noted on the company’s call, first-quarter production volumes — apparently the main source of consternation among those who dropped the company’s share price 1.5% on Thursday — were “in line with the projection presented at the analyst meeting in March.”)

Also described at the March session, however, was the company’s intention to spend about $190 billion during the next five years on various projects. Upstream, between this year and 2017, ExxonMobil has 28 major oil and gas projects in the hopper, most of which are liquids-based. In total, these start-ups are expected to add about a million oil-equivalent barrels to the company’s production during the five-year span.

On the final day of the quarter, for instance, extraction began at its Kearl plant facilities in Alberta, Canada. With initial regulatory approval for 345,000 barrels a day of production, the facility’s early output number will be about 110,000 barrels a day.

Production also started during the quarter at the Telok gas field offshore Malaysia in the South China Sea. When completed, the project will consist of two four-legged gas satellite platforms, which will serve as a base for 14 development wells.

Downstream, the company is in various stages of construction on facilities in Singapore, China, and Finland. In the chemicals portion of its businesses, an expansion at a facility — also in Singapore — has been completed, a major elastomers plant is being developed in Saudi Arabia, and plans are under way for yet another expansion — this one at the company’s huge integrated Baytown complex east of Houston.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!